Table 2 Outcomes over time using all carry forward intention-to-treat analysis
Standard Education (n = 75) | Fotonovela (n = 75) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Variable | Baseline | EV | 1 m | 6 m | 12 m | Baseline | EV | 1 m | 6 m | 12 m |
PHQ9 | 15.36 ± 4.09 | – | 8.33 ± 5.37 | 4.84 ± 5.21 | 4.79 ± 5.46 | 15.28 ± 4.24 | – | 8.64 ± 5.99 | 5.68 ± 5.40 | 5.85 ± 6.15 |
Model | Within-subjects F = 197.69***; Between-groups F = 0.703; η2 = 0.005 | |||||||||
GAD7 | 12.17 ± 4.57 | – | 7.13 ± 5.25 | 4.49 ± 4.85 | 4.08 ± 4.61 | 12.87 ± 4.56 | – | 7.79 ± 5.60 | 5.73 ± 5.26 | 5.71 ± 5.50 |
Model | Within-subjects F = 131.66***; Between-groups F = 2.833; η2 = 0.019 | |||||||||
DKM | 11.42 ± 2.00 | 12.08 ± 1.86 | 11.88 ± 1.91 | 11.97 ± 2.21 | 12.16 ± 2.15 | 12.12 ± 1.71 | 13.23 ± 1.94 | 12.95 ± 1.95 | 12.87 ± 1.94 | 13.03 ± 1.97 |
Model | Within-subjects F = 10.66***; Between-groups F = 12.09***; η2 = 0.082 | |||||||||
SCMHC | 0.38 ± 0.81 | 0.44 ± 0.88 | 0.37 ± 0.86 | 0.26 ± 0.67 | 0.16 ± 0.55 | 0.48 ± 0.86 | 0.16 ± 0.47 | 0.15 ± 0.56 | 0.13 ± 0.55 | 0.11 ± 0.48 |
Model | Within-subjects F = 6.26***; Between-groups F = 2.210; η2 = 0.015 | |||||||||
LSAS | 5.58 ± 3.06 | 5.71 ± 2.73 | 5.77 ± 2.74 | 5.88 ± 2.90 | 5.44 ± 2.70 | 6.56 ± 3.24 | 6.49 ± 3.16 | 6.57 ± 3.06 | 6.27 ± 3.06 | 6.13 ± 3.13 |
Model | Within-subjects F = 0.91; Between-groups F = 3.48+; η2 = 0.023 | |||||||||
SD | 13.21 ± 3.88 | 10.61 ± 1.92 | 10.76 ± 1.91 | 10.69 ± 2.21 | 10.86 ± 1.88 | 13.00 ± 3.60 | 10.66 ± 2.37 | 10.73 ± 2.09 | 10.72 ± 2.26 | 10.96 ± 2.09 |
Model | Within-subjects F = 35.11***; Between-groups F = 0.05; η2 = 0.001 | |||||||||